Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
199.30    2.60 (1.32%)
Bid:
199.00
Ask:
199.30
Spread: 0.30 (0.151%)
Market Cap: £2.00b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Covid-19 Update

1 Apr 2020 12:29

RNS Number : 4299I
B&M European Value Retail S.A.
01 April 2020
 

 

 

01 April 2020

B&M European Value Retail S.A.

(the "Company" or "Group ")

 

COVID-19 Update

 

As a significant retailer of food, drink, cleaning, healthcare, pet food and other essential products our B&M UK fascia and Heron Foods businesses have continued to trade following the guidance issued by the UK Government on 23 March 2020. Our first priority has been to protect and support our customers and colleagues. We have implemented Government advice regarding social distancing across our business.

 

In the UK, B&M traded from 656 stores and a further 293 Heron stores as at the 29 March 2020 year-end. We have reluctantly decided to temporarily close 49 B&M UK stores in light of current trading conditions affecting those locations. These are typically small format stores and in some cases are located within shopping centres that have largely ceased trading. Some 42 of the 49 stores are close to other larger B&M stores. We will review the trading patterns on an on-going basis and intend to re-open those stores as soon as normal shopping patterns resume.

 

The rest of our store estate in the UK continues to trade in line with Government guidance. The temporarily closed stores represent 3% and 2% of FY20 revenue and store contribution EBITDA respectively. Colleagues at the affected stores in the UK have been furloughed under the Government's Coronavirus Job Retention Scheme.

 

All our Heron Foods stores continue to trade. Our 101 stores in France under the Babou and B&M fascias are currently closed under the government restrictions in force there. As previously announced, we completed the sale of our German business on 27 March 2020.

 

We are grateful to our committed and hard-working colleagues for their remarkable effort and dedication in our stores and supply chain functions in helping customers at this very challenging time. To reward our store and distribution colleagues the UK business is now paying 10% enhancement to pay rates to reflect the additional workload that the guidelines impose. We have extended our B&M staff discount scheme to all NHS workers, and are donating £1m worth of food and toiletries to Food Banks across the UK.

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5766

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

Steve Webb, Investor Relations Director

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Daniel Yea, Maitland

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUPUMPCUPUGGG
Date   Source Headline
24th Nov 202310:35 amRNSPDMR Notification
21st Nov 202311:32 amRNSFinal Results of Tender Offer 3.625% Senior Notes
15th Nov 202310:11 amRNSTender Offer Indicative Maximum Acceptance Amount
14th Nov 20235:52 pmRNSPricing of £250 Million Senior Secured Notes
13th Nov 20232:28 pmRNSPre Stabilisation Notice
13th Nov 20239:39 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:30 amRNSTender Offer
13th Nov 20239:27 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:07 amRNS£250 Million Senior Secured Notes Offering
9th Nov 20237:00 amRNSFY24 Interim Results
3rd Oct 20237:25 amRNSTotal Voting Rights
22nd Sep 202311:33 amRNSDirector Appointment and Results of OGM
19th Sep 20238:50 amRNSTiming of announcement of Half Year Results
7th Sep 20232:19 pmRNSNotification of major holdings
7th Sep 20231:31 pmRNSDirector/PDMR Shareholding
5th Sep 20239:48 amRNSAcquisition of Assets from Wilko Ltd (in admin)
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Aug 20239:08 amRNSNotice of Ordinary General Meeting- replace
14th Aug 20237:00 amRNSNotice of Ordinary General Meeting
9th Aug 20234:02 pmRNSGrant of share options to PDMR
2nd Aug 20239:21 amRNSGrant of options to senior managers
2nd Aug 20239:18 amRNSGrant of options to Directors
28th Jul 20237:00 amRNSGroup Trading Director Retention Agreement
27th Jul 20231:42 pmRNSTR-1 Correction Announcement
26th Jul 20234:15 pmRNSTR-1 Notification of major holdings
26th Jul 20233:33 pmRNSBoard change
26th Jul 20238:45 amRNSEGM Voting results announcement
26th Jul 20238:15 amRNSAGM 2023 Voting results announcement
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.